Wells Fargo’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$114K Buy
15,078
+879
+6% +$6.65K ﹤0.01% 4713
2025
Q1
$78.4K Sell
14,199
-1,682
-11% -$9.29K ﹤0.01% 4774
2024
Q4
$91.3K Buy
15,881
+6,518
+70% +$37.5K ﹤0.01% 4758
2024
Q3
$97K Buy
9,363
+395
+4% +$4.09K ﹤0.01% 4644
2024
Q2
$116K Sell
8,968
-15,941
-64% -$207K ﹤0.01% 4485
2024
Q1
$435K Buy
24,909
+18,731
+303% +$327K ﹤0.01% 3638
2023
Q4
$58.1K Buy
6,178
+1,200
+24% +$11.3K ﹤0.01% 4797
2023
Q3
$55.6K Sell
4,978
-19,505
-80% -$218K ﹤0.01% 4783
2023
Q2
$524K Buy
24,483
+10,531
+75% +$225K ﹤0.01% 3704
2023
Q1
$564K Buy
13,952
+13,136
+1,610% +$531K ﹤0.01% 3519
2022
Q4
$38K Sell
816
-1,045
-56% -$48.6K ﹤0.01% 4682
2022
Q3
$96K Sell
1,861
-219
-11% -$11.3K ﹤0.01% 4327
2022
Q2
$98K Sell
2,080
-14,604
-88% -$688K ﹤0.01% 4389
2022
Q1
$1.19M Sell
16,684
-5,659
-25% -$403K ﹤0.01% 3520
2021
Q4
$1.67M Buy
22,343
+6,835
+44% +$511K ﹤0.01% 3442
2021
Q3
$881K Sell
15,508
-5,157
-25% -$293K ﹤0.01% 4090
2021
Q2
$910K Buy
20,665
+16,468
+392% +$725K ﹤0.01% 4037
2021
Q1
$207K Sell
4,197
-38,047
-90% -$1.88M ﹤0.01% 4814
2020
Q4
$1.78M Buy
42,244
+1,669
+4% +$70.3K ﹤0.01% 3536
2020
Q3
$1.86M Sell
40,575
-918
-2% -$42K ﹤0.01% 3307
2020
Q2
$2.08M Buy
41,493
+7,142
+21% +$359K ﹤0.01% 3184
2020
Q1
$1.77M Buy
34,351
+2,257
+7% +$116K ﹤0.01% 3041
2019
Q4
$1.98M Buy
32,094
+2,148
+7% +$133K ﹤0.01% 3322
2019
Q3
$1.8M Buy
29,946
+1,120
+4% +$67.3K ﹤0.01% 3377
2019
Q2
$2.43M Buy
28,826
+1,668
+6% +$141K ﹤0.01% 3144
2019
Q1
$2.6M Sell
27,158
-426
-2% -$40.7K ﹤0.01% 3119
2018
Q4
$1.95M Buy
27,584
+3,529
+15% +$250K ﹤0.01% 3231
2018
Q3
$2.06M Sell
24,055
-18,716
-44% -$1.6M ﹤0.01% 3341
2018
Q2
$4.96M Buy
42,771
+17,465
+69% +$2.02M ﹤0.01% 2673
2018
Q1
$2.05M Buy
25,306
+1,918
+8% +$155K ﹤0.01% 3325
2017
Q4
$1.37M Buy
23,388
+5,191
+29% +$305K ﹤0.01% 3623
2017
Q3
$852K Buy
18,197
+4,886
+37% +$229K ﹤0.01% 3892
2017
Q2
$479K Sell
13,311
-8,083
-38% -$291K ﹤0.01% 4138
2017
Q1
$660K Buy
21,394
+9,674
+83% +$298K ﹤0.01% 3973
2016
Q4
$393K Buy
11,720
+5,265
+82% +$177K ﹤0.01% 4230
2016
Q3
$172K Sell
6,455
-73,692
-92% -$1.96M ﹤0.01% 4389
2016
Q2
$1.77M Sell
80,147
-1,003
-1% -$22.1K ﹤0.01% 3020
2016
Q1
$2.38M Sell
81,150
-8,391
-9% -$246K ﹤0.01% 2773
2015
Q4
$2.96M Buy
89,541
+52,600
+142% +$1.74M ﹤0.01% 2670
2015
Q3
$1.34M Buy
36,941
+1,755
+5% +$63.4K ﹤0.01% 3232
2015
Q2
$1.58M Buy
35,186
+963
+3% +$43.3K ﹤0.01% 3209
2015
Q1
$1.05M Sell
34,223
-16,501
-33% -$505K ﹤0.01% 3457
2014
Q4
$2.58M Buy
50,724
+24,748
+95% +$1.26M ﹤0.01% 2800
2014
Q3
$1.03M Sell
25,976
-683
-3% -$27K ﹤0.01% 3414
2014
Q2
$1.15M Sell
26,659
-27,248
-51% -$1.17M ﹤0.01% 3388
2014
Q1
$2.16M Buy
53,907
+22,513
+72% +$900K ﹤0.01% 2937
2013
Q4
$857K Buy
31,394
+14,026
+81% +$383K ﹤0.01% 3488
2013
Q3
$398K Buy
+17,368
New +$398K ﹤0.01% 3838